axicabtagene ciloleucel
gilead,daiichi sankyo
['pcnsl', ' cana ', 'axi-cel', 'lymphoma']
axi-cel for cns lymphoma, cr 67%, acceptable toxicity profile #ash22 
BMTCI fellow @moffittnews 2023 | BMT fellowship @MayoClinic 2022 | Hem/Onc Fellowship @AUB_Lebanon 2021 | EBMT Young Ambassador 2018 | My tweets are my own